Red Nucleus

9K posts

Red Nucleus banner
Red Nucleus

Red Nucleus

@RedNucleusHQ

Advancing knowledge to improve lives. 🔴🧠

Global 🌎🌍🌏 Katılım Haziran 2010
3.3K Takip Edilen3.3K Takipçiler
Sabitlenmiş Tweet
Red Nucleus
Red Nucleus@RedNucleusHQ·
Meet your strategic congress objectives with KOL engagement services scalable to your needs, and ensure your data generation planning and key messaging reflect insights from top KOLs, and allied HCPs. info@rednucleus.com | rednucleus.com/contact-us 🔴🧠 #medcomms
Red Nucleus tweet media
English
1
1
0
903
Red Nucleus
Red Nucleus@RedNucleusHQ·
Meet your strategic congress objectives with KOL engagement services scalable to your needs, and ensure your data generation planning and key messaging reflect insights from top KOLs, and allied HCPs. info@rednucleus.com | rednucleus.com/contact-us 🔴🧠 #medcomms
Red Nucleus tweet media
English
1
1
0
903
Red Nucleus
Red Nucleus@RedNucleusHQ·
To encourage the early launch of new drugs in Japan, Chuikyo introduced a “rapid launch premium" to take effect starting this month. Download our PDF for insights on how this will affect your pricing strategies from LinkedIn: linkedin.com/feed/update/ur… 🔴🧠 #WODC2024 #ASEMBIA2024
Red Nucleus tweet media
English
1
0
0
226
Red Nucleus
Red Nucleus@RedNucleusHQ·
We’re excited to share our innovative approaches using video for hybrid and decentralized trials to collect powerful patient-centered data. We focus on how to the overcome pitfalls associated with endpoint sensitivity and improve the probability of optimal access for patients.
English
0
0
1
93
Red Nucleus
Red Nucleus@RedNucleusHQ·
Join us at #WODC2024 in Boston! Are you interested in how to maximize the value and impact of patient centered evidence? Start leveraging our integrated approaches from trials to access—reach out to us today at info@rednucleus.com or via rednucleus.com/contact-us 🔴🧠
GIF
English
1
0
1
173
Red Nucleus
Red Nucleus@RedNucleusHQ·
In this poster we will explore: 🔴 Launch list prices and list price differentials between markets for top high-revenue drugs between 2020-23 🟣 Price differentials between markets by therapeutic area, orphan drug status, biologics vs. non-biologics 🔵 Potential rationales
English
1
0
0
89
Red Nucleus
Red Nucleus@RedNucleusHQ·
Visit the Red Nucleus MACS team at ISPOR in Atlanta! We are presenting a poster on trends in launch prices across US, Canada, EU4 and UK for high-revenue drugs. 10:30 AM – 1:30 PM, May 7, 2024 Poster Session 3, poster code EE276 🔴🧠 #ISPOR2024 #MarketAccess
Red Nucleus tweet media
English
1
0
0
181
Red Nucleus
Red Nucleus@RedNucleusHQ·
Our support services can include: 🟣 Guiding KOL identification; 🟣 Outreach & scheduling; 🟣 Developing discussion guides and talking points; 🟣 Creation of post-meeting summaries; 🟣 Quickly identifying action items and key takeaways; and more.
English
0
0
0
73
Red Nucleus
Red Nucleus@RedNucleusHQ·
Meet our team at the AMCP Annual Meeting in New Orleans! Let's connect and discuss how our Market Access & Commercialization (MACS) team can help you achieve market success. We hope to see you there, April 15-18. info@rednucleus.com / rednucleus.com/contact-us?utm… 🔴🧠 #AMCP2024
Red Nucleus tweet media
English
0
0
0
133
Red Nucleus
Red Nucleus@RedNucleusHQ·
🟣 What is the relationship between US prevalence and launch price, and how do other product attributes affect price? 🔵 What is the impact of being first-in-indication and/or a first-in-class product on US launch price? #ISPOR2024
English
0
0
0
65
Red Nucleus
Red Nucleus@RedNucleusHQ·
We will explore: 🔴 What are the common attributes of orphan drugs and how have these attributes evolved over time? #ISPOR2024
English
1
0
0
74
Red Nucleus
Red Nucleus@RedNucleusHQ·
Come visit the Red Nucleus MACS team at #ISPOR2024 in Atlanta! We are presenting 3 posters leveraging proprietary data from our 2015-22 US non-oncology orphan drug database. 🔴🧠 For your poster copy, contact Dan Krieger dkrieger@rednucleus.com or via: rednucleus.com/contact-us?utm…
Red Nucleus tweet media
English
1
0
0
124